Pharming Group (OTCMKTS:PHGUF) Shares Gap Down – Time to Sell?

Shares of Pharming Group NV (OTCMKTS:PHGUF) gapped down before the market opened on Wednesday . The stock had previously closed at $1.37, but opened at $1.20. Pharming Group shares last traded at $1.20, with a volume of 10,000 shares.

Pharming Group Stock Performance

The firm has a market cap of $1.03 billion, a price-to-earnings ratio of 153.00 and a beta of 0.61. The company has a current ratio of 2.79, a quick ratio of 2.07 and a debt-to-equity ratio of 0.50. The stock’s 50 day moving average is $1.48 and its 200 day moving average is $1.23.

Pharming Group (OTCMKTS:PHGUF) last posted its earnings results on Thursday, November 6th. The biotechnology company reported $0.01 EPS for the quarter. The company had revenue of $97.30 million for the quarter, compared to the consensus estimate of $80.18 million. Pharming Group had a negative return on equity of 3.31% and a negative net margin of 2.19%.

About Pharming Group

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.